Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696760 · ClinicalTrials.gov registry record · NA
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01696760 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 12 participants.
The verdict
NCT01696760, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a research study to compare the efficacy of aspirin (acetylsalicylic acid) and pneumatic compression devices versus enoxaparin (also known as Lovenox) and pneumatic compression devices in preventing deep vein thrombosis in patients with pelvic and lower extremity malignant tumors and undergoing surgery. Pneumatic compression devices are also known as sequential compression devices and are inflatable compression sleeves that are placed around patient's legs to reduce the risk of clot formation deep vein thrombosis. Pneumatic compression devices are made of a soft material that wraps around the lower leg and periodically squeeze the calf. A deep vein thrombosis is a blood clot. Most hospitalized patients wear these as a preventive measure. Pneumatic compression devices alone are not sufficient to prevent deep vein thrombosis formation. Therefore, medicines, such as aspirin and enoxaparin are utilized. Both drugs are used for prevention, but there are no studies in patients with musculoskeletal tumors which have determined whether one drug is better than another. The knowledge gained from this study will determine whether aspirin and pneumatic compression devices is the same or better than enoxaparin and pneumatic compression devices in preventing deep vein thrombosis in this patient population and may result in fewer wound and bleeding complications
Interventions
- DRUG enoxaparin
- DRUG acetylsalicylic acid
- DEVICE PCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01696760
The ClinicalTrials.gov registry entry for NCT01696760 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which enoxaparin is the first listed.
NCT01696760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01696760 about?
NCT01696760 is a clinical study titled "Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology". This is a research study to compare the efficacy of aspirin (acetylsalicylic acid) and pneumatic compression devices versus enoxaparin (also known as Lovenox) and pneumatic compression devices in preventing deep vein thrombosis in patients with pelvic and lower extremity malignant tumors and undergo...
What is the current status of trial NCT01696760?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01696760?
The interventions under investigation include: enoxaparin (DRUG), acetylsalicylic acid (DRUG), PCD (DEVICE).
Who is sponsoring clinical trial NCT01696760?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.